Clinical Trial Update: Perioperative Treatment With Zoledronic Acid in Patients With Resectable Pancreas Cancer [Phase 1]

View source ↗

Summary

This document reports a Phase 1 trial evaluating perioperative zoledronic acid in patients with resectable pancreatic cancer. The study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Adenocarcinoma | Phase 1 | Status: TERMINATED